The Cooper Companies Announces Executive Management Changes
May 23 2018 - 4:15PM
Holly Sheffield to Join as EVP, Chief Strategy
Officer
The Cooper Companies, Inc. (NYSE:COO) today announced the following
key management changes:
Holly Sheffield has been appointed Executive Vice President and
Chief Strategy Officer of The Cooper Companies, effective June 4,
2018. In this position, Holly will be responsible for corporate
strategy, business development and global human resources with a
strong focus on driving long-term shareholder value. Holly
will report directly to Albert White, President and CEO.
Sheffield joins Cooper from UBS Securities LLC where she was
Global Head of Medical Technology within the firms’ Healthcare
Banking group. Holly was also co-head of the America’s
Investment Bank Diversity and Inclusion Council at UBS along with
involvement in several other cultural initiatives within the
bank. Prior to UBS, she spent 13 years at Credit Suisse where
she was a Managing Director in Healthcare Banking in San Francisco
and New York. Sheffield holds an MBA from Columbia Business
School and a BA from Cornell University.
Dr. Robert Auerbach, Executive Vice President, Chief Strategy
Officer and Chief Medical Officer of CooperSurgical, has been
promoted to President of CooperSurgical, effective April 17,
2018. In his new role, he is responsible for CooperSurgical’s
worldwide business, reporting directly to Albert White.
Auerbach has held a number of leadership roles since joining
CooperSurgical in 2005. Prior to joining CooperSurgical, Auerbach
was a member of Yale’s clinical faculty in the School of
Medicine. He completed his specialty training in obstetrics
and gynecology at Yale in 1988. Auerbach succeeds Paul
Remmell who has transitioned out of the company after a successful
career spanning 27 years.
Commenting on the announcement, White said, “I am very pleased
with Holly and Bob’s appointments to our executive management
team. Holly brings extensive knowledge and experience in the
medical device space, and she will serve as an integral advisor and
partner to our leadership team. Bob’s extensive experience as a
leader within CooperSurgical for many years, combined with his
technical expertise, makes him the ideal candidate to drive
CooperSurgical’s global success.”
About The Cooper CompaniesThe Cooper Companies,
Inc. ("Cooper") is a global medical device company publicly traded
on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of
Life Company™ with a focus on delivering shareholder value. Cooper
operates through two business units, CooperVision and
CooperSurgical. CooperVision brings a refreshing perspective on
vision care with a commitment to developing a wide range of
high-quality products for contact lens wearers and providing
focused practitioner support. CooperSurgical is committed to
advancing the health of families with its diversified portfolio of
products and services focusing on women’s health, fertility and
diagnostics. Headquartered in Pleasanton, CA, Cooper has more than
11,000 employees with products sold in over 100 countries. For more
information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT:
Kim DuncanVice President, Investor RelationsThe Cooper
Companies, Inc.ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2023 to Apr 2024